ArticleOncotarget2018

Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production.

Azin Jafari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.